Abstract
Twenty-eight acyl hydrazides (1-28) are subjected for nitric oxide scavenging activities and their structureactivity relationship (SAR) is established. Compounds 1-28 showed a varying degree of activity having IC50 values in the range of 9.1 ± 6.5 - 231.1 μM. It was found that twenty-five (25) out of twenty-eight (28) compounds, showed an excellent nitric oxide scavenging activity. It was observed that the activity mainly depends on the substitution on acyl hyrazide moiety. 3-Propylpyrozole-5-carbohydrazide (27) was found to be the most active in the series with an IC50 value of 9.1 μM. Thus, compound 27 may serve as a lead compound for further development as potent antioxidant agent.
Keywords: Acyl hydrazides, Free radicals, Reactive oxygen species (ROS), Nitric oxides scavengers, Antioxidant, Lead molecules, peroxynitrite, tonic relaxation, antitumor, antiglycation, antituberculosis, Nitroprusside sodium, heterocyclic, radical-scavenging, antimicrobial, conventional synthetic methods
Letters in Drug Design & Discovery
Title: Acyl Hydrazides: Potent Antioxidants
Volume: 9 Issue: 2
Author(s): Khalid Mohammed Khan, Mubeen Rani, Nida Ambreen, Asma Ejaz, Shahnaz Perveen, Syed Moazzam Haider, Mohammad Iqbal Choudhary and Wolfgang Voelter
Affiliation:
Keywords: Acyl hydrazides, Free radicals, Reactive oxygen species (ROS), Nitric oxides scavengers, Antioxidant, Lead molecules, peroxynitrite, tonic relaxation, antitumor, antiglycation, antituberculosis, Nitroprusside sodium, heterocyclic, radical-scavenging, antimicrobial, conventional synthetic methods
Abstract: Twenty-eight acyl hydrazides (1-28) are subjected for nitric oxide scavenging activities and their structureactivity relationship (SAR) is established. Compounds 1-28 showed a varying degree of activity having IC50 values in the range of 9.1 ± 6.5 - 231.1 μM. It was found that twenty-five (25) out of twenty-eight (28) compounds, showed an excellent nitric oxide scavenging activity. It was observed that the activity mainly depends on the substitution on acyl hyrazide moiety. 3-Propylpyrozole-5-carbohydrazide (27) was found to be the most active in the series with an IC50 value of 9.1 μM. Thus, compound 27 may serve as a lead compound for further development as potent antioxidant agent.
Export Options
About this article
Cite this article as:
Mohammed Khan Khalid, Rani Mubeen, Ambreen Nida, Ejaz Asma, Perveen Shahnaz, Moazzam Haider Syed, Iqbal Choudhary Mohammad and Voelter Wolfgang, Acyl Hydrazides: Potent Antioxidants, Letters in Drug Design & Discovery 2012; 9 (2) . https://dx.doi.org/10.2174/157018012799079798
DOI https://dx.doi.org/10.2174/157018012799079798 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension using a Bioinformatics/Network Topology-based Strategy
Combinatorial Chemistry & High Throughput Screening Evidence of Stability of Medicines Repackaged in Compliance Aids: A Review
Current Drug Safety Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments
Current Cardiology Reviews Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region through its Anti-Oxidant and Anti-Apoptotic Activities
CNS & Neurological Disorders - Drug Targets Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry New Alternative Anticoagulants in Atrial Fibrillation: The Move Beyond Warfarin.
Reviews on Recent Clinical Trials The Role of Intravascular Ultrasound to Guide Drug-Eluting Stents Implantation
Cardiovascular & Hematological Agents in Medicinal Chemistry Levosimendan: From Basic Science to Clinical Trials
Recent Patents on Cardiovascular Drug Discovery Netrin-1 in Post-stroke Neuroprotection: Beyond Axon Guidance Cue
Current Neuropharmacology Current Understanding of Cardiac Troponins Metabolism: A Narrative Review
Current Medicinal Chemistry Role of Iodine, Selenium and Other Micronutrients in Thyroid Function and Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications
Current Drug Targets - CNS & Neurological Disorders Dissecting the Mechanisms of Thrombogenesis and Atherosclerosis for Neurodegenerative Disorders
Current Neurovascular Research Exercise and Ischemic Preconditioning
Current Cardiology Reviews In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Recent Patents on CNS Drug Discovery (Discontinued) Social Networks and Health in Women: Results from a Qualitative Study in Iran
Current Women`s Health Reviews Commentary (Research Highlights: Transcranial Drug Delivery for Neurological Disorders)
CNS & Neurological Disorders - Drug Targets Tert-butylhydroquinone Mitigates Renal Dysfunction in Pregnant Diabetic Rats <i>via</i> Attenuation of Oxidative Stress and Modulation of the iNOs/ NFkB/TNF Alpha Signalling Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology